🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Antiviral resistance remains an important issue for long-term NA therapy. F...
Status
Completed
Location
Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2014-05-12
Trial ID
NCT02019966
The purpose of this study is to better define the intensive care unit popul...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02689531
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
This is a prospective observational study assessing the clinical outcomes o...
Status
Completed
Location
Bwaila District Hospital
Start Date
2016-10-19
Trial ID
NCT02960919
This is a Phase II parallel group randomized controlled trial with 294 adol...
Status
Recruiting
Location
UConn Health
Start Date
2024-11-26
Trial ID
NCT06395467
This study hypothesizes that electroacupuncture combined with self-administ...
Status
Recruiting
Location
Qinghai University Affiliated Hospital
Start Date
2024-10-08
Trial ID
NCT06602167
The aim of this study is to test whether when using the Vestibular Rehabili...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2022-05-23
Trial ID
NCT05436067
Treatments Being Tested
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
A prospective, randomized, placebo controlled, double-blinded study at a si...
Status
Terminated
Location
SJHMC/Barrow Neurosurgical Associates
Start Date
2015-03-01
Trial ID
NCT02276911
Treatments Being Tested
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested